Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Estimated NAV at 31 January 2015

16 Feb 2015 07:00

RNS Number : 9246E
Standard Life Euro Pri Eqty Tst PLC
16 February 2015
 

16 February 2015

STANDARD LIFE EUROPEAN PRIVATE EQUITY TRUST PLC ("SLEPET" OR "THE COMPANY") ANNOUNCES ITS ESTIMATED NET ASSET VALUE ("NAV") AT 31 JANUARY 2015

· ESTIMATED NAV AT 31 JANUARY 2015 WAS 247.9 PENCE PER SHARE (ESTIMATED NAV AT 31 DECEMBER 2014 WAS 258.6 PENCE PER SHARE)

· THE 10.7 PENCE MOVEMENT IN NAV DURING THE MONTH PRIMARILY REFLECTED:

· PAYMENT OF THE FINAL DIVIDEND FOR THE YEAR ENDED 30 SEPTEMBER 2014 OF 5.0 PENCE PER ORDINARY SHARE ON 30 JANUARY 2015

· UNREALISED FOREIGN EXCHANGE LOSSES ON THE PORTFOLIO ARISING FROM A 3.3% DECLINE IN THE EURO

· SLEPET RECEIVED £2.9 MILLION OF DISTRIBUTIONS AND PAID £1.8 MILLION OF DRAW DOWNS DURING THE MONTH OF JANUARY

· SLEPET HAD £238.9 MILLION OF OUTSTANDING COMMITMENTS AT 31 JANUARY 2015

SLEPET's valuation policy for private equity funds is based on the latest valuations reported by the managers of the funds in which SLEPET has holdings. In the case of SLEPET's valuation at 31 January 2015, the majority of reported valuations (accounting for circa 99% by value) were dated 30 September 2014.

 

Estimated NAV

At 31 January 2015, SLEPET's estimated NAV was 247.9 pence per share (estimated net assets £390.8 million), representing a 4.1% per share decrease from the estimated NAV at 31 December 2014 of 258.6 pence per share (estimated net assets £407.8 million).

SLEPET paid a final dividend for the year ended 30 September 2014 of 5.0 pence per ordinary share on 30 January 2015. The cash cost of the dividend was £7.9 million.

 

Draw downs and distributions

SLEPET paid £1.8 million of draw downs and received £2.9 million of distributions during the month. The distributions received generated net realised gains and income of £0.7 million.

 

Commitments

A new commitment of £28.0 million was made to Exponent Private Equity Partners III in January. The Company had £238.9 million of outstanding commitments at 31 January 2015.

 

Balance sheet and credit facility

The Company had liquid resources of £59.8 million at 31 January 2015, comprising a cash balance, including holdings in money market funds, of £29.5 million and £30.3 million invested at value (£29.4 million at cost) in UK and European equity index tracker funds. The Company has an undrawn £80 million syndicated revolving credit facility led by The Royal Bank of Scotland plc that expires in December 2016.

 

Future announcements

The Company is expecting to announce its actual NAV at 31 December 2014 on 19 March 2015 and will announce its estimated NAV at 28 February 2015 at the same time.

 

 

 

 

Additional detail about SLEPET's NAV and investment diversification can be found on SLEPET's website. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website is incorporated into, or forms part of, this announcement.

For further information please contact:-

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

Valuation Methodology

Unquoted investments are stated at the directors' estimate of fair value and follow the recommendations of EVCA and BVCA. The estimate of fair value is normally the latest valuation placed on a fund by its manager at the balance sheet date. The valuation policies used by the manager in undertaking that valuation will generally be in line with the joint publication from EVCA and BVCA, 'International Private Equity and Venture Capital Valuation guidelines'. Where formal valuations are not completed at the balance sheet date the last available valuation from the fund manager is adjusted for any subsequent cashflows occurring between the valuation date and the balance sheet date. The Company's Manager may further adjust such valuations to reflect any changes in circumstances from the last manager's formal valuation date to arrive at the estimate of fair value. Quoted investments are valued based on quoted prices as of the last day of the relevant period.

The Company intends to release regular estimated NAV updates around ten business days after each month end, while continuing to issue quarterly trading statements. A breakdown of SLEPET's portfolio can be obtained in the January 2015 monthly factsheet, which is published on the Manager's website at www.slcapital.com/IT_European_Private_Equity/getLatest.pdf

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTJMFTMBIBBJA
Date   Source Headline
1st Jul 200911:19 amRNSTotal Voting Rights
30th Jun 20093:31 pmRNSDirector/PDMR Shareholding
26th Jun 20099:00 amRNSIssue of Equity
9th Jun 200912:17 pmRNSDirector/PDMR Shareholding
3rd Jun 20092:22 pmRNSDirector/PDMR Shareholding
2nd Jun 200910:20 amRNSDirector/PDMR Shareholding
29th May 20097:00 amRNSHalf Yearly Report
24th Mar 20097:30 amRNSTrading Statement
24th Feb 200910:15 amRNSSecondary Sales
3rd Feb 20092:37 pmRNSHolding(s) in Company
2nd Feb 200912:37 pmRNSDirector/PDMR Shareholding
2nd Feb 200912:34 pmRNSDirector/PDMR Shareholding
2nd Feb 200912:30 pmRNSTotal Voting Rights
2nd Feb 200911:23 amRNSHolding(s) in Company
27th Jan 200910:10 amRNSIssue of Shares following Scrip Dividend
26th Jan 20094:20 pmRNSInterim Management Statement
26th Jan 20094:08 pmRNSResult of AGM
26th Jan 200912:19 pmRNSDirectorate Change
14th Jan 20097:00 amRNSDisposal of Private Equity Fund Interests
8th Jan 20093:00 pmRNSScrip Dividend reference price
5th Jan 20094:05 pmRNSAnnual Financial Report
5th Jan 20094:00 pmRNSAnnual Information Update
18th Dec 20084:00 pmRNSAppointment of Broker
18th Dec 200811:46 amRNSDirector/PDMR Shareholding
17th Dec 20082:43 pmRNSDoc re. Annual Report
4th Dec 20084:49 pmRNSDirector/PDMR Shareholding
1st Dec 20087:00 amRNSFinal Results
27th Nov 20082:21 pmRNSDirectorate Change
23rd Sep 20087:00 amRNS3rd Quarter Trading Statement
22nd Sep 20082:37 pmRNSResult of EGM
22nd Aug 20087:00 amRNSCircular re EGM
30th Jul 20084:42 pmRNSSecond Price Monitoring Extn
30th Jul 20084:36 pmRNSPrice Monitoring Extension
24th Jul 20087:30 amRNSInterim Management Statement
15th Jul 20084:37 pmRNSDirector/PDMR Shareholding
30th Jun 200810:16 amRNSDirector Declaration
17th Jun 20084:22 pmRNSDoc re. Interim Report
30th May 20087:00 amRNSInterim Results
20th May 20083:18 pmRNSHolding(s) in Company
18th Mar 20082:58 pmRNSDirector/PDMR Shareholding
18th Mar 20087:00 amRNSTrading Statement
30th Jan 200810:31 amRNSDirector/PDMR Shareholding
29th Jan 20089:00 amRNSInterim Management Statement
28th Jan 20084:20 pmRNSResult of AGM
10th Jan 200810:31 amRNSAnnual Information Update
3rd Jan 200810:23 amRNSPortfolio Update
3rd Jan 200810:21 amRNSTotal Voting Rights
27th Dec 200710:33 amRNSDirector/PDMR Shareholding
20th Dec 20072:00 pmRNSDoc re. Annual Report
28th Nov 20077:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.